News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,951 Results
Type
Article (21774)
Company Profile (236)
Press Release (516938)
Multimedia
Podcasts (262)
Webinars (24)
Section
Business (183074)
Career Advice (1065)
Deals (28354)
Drug Delivery (144)
Drug Development (61369)
Employer Resources (149)
FDA (11060)
Job Trends (10466)
News (263429)
Policy (21020)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (2)
2027 BioCapital Standard (2)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (10)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (5)
2027 Genetown Digital (1)
2027 Genetown Elite (4)
2027 Genetown Premier (1)
2027 Genetown Standard (4)
2027 NextGen (7)
2027 Pharm Country Digital (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
40 Under 40 (2)
Academia (939)
Academic (1)
Accelerated approval (46)
ADA (27)
Adcomms (18)
Allergies (129)
Alliances (37457)
ALS (165)
Alzheimer's disease (1256)
Antibody-drug conjugate (ADC) (462)
Approvals (11512)
Artificial intelligence (633)
ASCO (214)
Autoimmune disease (325)
Automation (47)
Bankruptcy (303)
Belgium (11)
Best Places to Work (7570)
BIO (81)
Biologics (57)
BIOSECURE Act (17)
Biosimilars (174)
BioSpace Insights (256)
Biotechnology (141)
Bispecific (29)
Bladder cancer (159)
Brain cancer (49)
Breast cancer (603)
Cancer (4780)
Cardiovascular disease (362)
Career advice (946)
Career pathing (46)
CAR-T (277)
CDC (33)
CDMO (174)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (776)
Cervical cancer (38)
Clinical research (54159)
Collaboration (1752)
Commercialization (38)
Company closure (8)
Compensation (1643)
Complete response letters (59)
COVID-19 (1918)
CRISPR (105)
CRO (4)
C-suite (1099)
Cystic fibrosis (109)
Data (6992)
Decentralized trials (3)
Denatured (110)
Depression (146)
Dermatology (101)
Diabetes (457)
Diagnostics (4765)
Digital health (46)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (311)
Drug pricing (98)
Drug shortages (15)
Duchenne muscular dystrophy (240)
Earnings (76853)
Editorial (58)
Employer branding (24)
Employer resources (125)
ESMO (281)
Events (96521)
Executive appointments (893)
Eye disease (7)
FDA (14189)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (2)
Friedreich's ataxia (25)
Frontotemporal dementia (29)
Funding (1477)
Gene editing (207)
Generative AI (56)
Gene therapy (613)
GLP-1 (720)
Government (1922)
Grass and pollen (3)
Guidances (294)
Healthcare (10405)
Hematology (110)
HIV (64)
Huntington's disease (52)
Idiopathic pulmonary fibrosis (8)
IgA nephropathy (105)
Immunology and inflammation (237)
Immuno-oncology (102)
Indications (197)
Infectious disease (2174)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (104)
Intellectual property (294)
Interviews (173)
IPO (13257)
IRA (27)
Job creations (3007)
Job search strategy (816)
JPM (61)
Kidney cancer (19)
Kidney disease (103)
Labor market (140)
Layoffs (386)
Leadership (33)
Legal (5877)
Licensing (61)
Liver cancer (67)
Longevity (39)
Lung cancer (693)
Lung diease (15)
Lymphoma (300)
Machine learning (50)
Management (37)
Manufacturing (984)
Marketing (22)
MASH (167)
Medical affairs (2)
Medical device (9155)
Medtech (9357)
Mergers & acquisitions (16256)
Metabolic disorders (1161)
mRNA (251)
Multiple sclerosis (137)
Multispecific (5)
NASH (12)
Netherlands (8)
Neurodegenerative disease (357)
Neuropsychiatric disorders (72)
Neuroscience (2479)
Neurotech (3)
NextGen: Class of 2026 (3981)
Non-profit (1078)
Now hiring (91)
Obesity (485)
Opinion (215)
Ovarian cancer (200)
Pain (216)
Pancreatic cancer (271)
Parkinson's disease (255)
Partnered (41)
Patents (584)
Patient advocacy (4)
Patient recruitment (620)
Patient selection (55)
Peanut (37)
People (46302)
Peptides (18)
Pharmaceutical (43)
Pharmacy benefit managers (18)
Phase 1 (17581)
Phase 2 (24409)
Phase 3 (17001)
Pipeline (9323)
Policy (244)
Postmarket research (1669)
Preclinical (7390)
Press Release (49)
Prostate cancer (231)
Psychedelics (65)
Radioligand (2)
Radiopharmaceuticals (263)
Rare diseases (962)
Real estate (3919)
Recruiting (56)
Regenerative medicine (18)
Regulatory (17573)
Reports (82)
Research institute (979)
Resumes & cover letters (154)
Rett syndrome (51)
RNA editing (28)
RSV (60)
Schizophrenia (132)
Series A (292)
Series B (198)
Service/supplier (6)
Sickle cell disease (87)
Special edition (34)
Spinal muscular atrophy (111)
Sponsored (35)
Startups (2896)
State (1)
Stem cells (5)
Stomach cancer (7)
Substance use disorders (20)
Supply chain (87)
Switzerland (1)
Tariffs (35)
Tax incentives (2)
The Weekly (149)
Vaccines (873)
Venture capital (140)
Weight loss (274)
Wet AMD (4)
Women's health (128)
Women in leadership (1)
Worklife (22)
Date
Today (27)
Last 7 days (545)
Last 30 days (1965)
Last 365 days (22087)
2026 (18470)
2025 (21819)
2024 (25941)
2023 (29602)
2022 (38607)
2021 (41002)
2020 (36502)
2019 (26110)
2018 (19578)
2017 (21981)
2016 (21353)
2015 (26994)
2014 (23783)
2013 (19814)
2012 (21882)
2011 (22021)
2010 (21652)
Location
Africa (519)
Alabama (85)
Alaska (2)
Arizona (333)
Arkansas (13)
Asia (24656)
Australia (3147)
California (13818)
Canada (3534)
China (949)
Colorado (557)
Connecticut (492)
Delaware (293)
Europe (37934)
Florida (2008)
Georgia (423)
Hawaii (4)
Idaho (51)
Illinois (895)
India (89)
Indiana (367)
Iowa (23)
Japan (499)
Kansas (118)
Kentucky (38)
Louisiana (34)
Maine (28)
Maryland (1374)
Massachusetts (9222)
Michigan (336)
Minnesota (682)
Mississippi (6)
Missouri (95)
Montana (21)
Nebraska (14)
Nevada (169)
New Hampshire (71)
New Jersey (3012)
New Mexico (22)
New York (3215)
North Carolina (1481)
North Dakota (5)
Northern California (7011)
Ohio (360)
Oklahoma (17)
Oregon (23)
Pennsylvania (2559)
Puerto Rico (27)
Rhode Island (39)
South America (682)
South Carolina (84)
South Dakota (1)
Southern California (5649)
Tennessee (138)
Texas (2316)
United States (44883)
Utah (449)
Vermont (1)
Virginia (191)
Washington D.C. (53)
Washington State (1051)
West Virginia (2)
Wisconsin (90)
Wyoming (1)
538,951 Results for "mustang bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Dren Bio lands $350M to push rare blood cancer therapy toward market
After Sanofi paid $600 million in cash to acquire Dren Bio’s bispecific last year, the biotech has secured a hefty financing to fund late-stage development and commercial preparations for its lead asset.
October 29, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
November 1, 2026
·
5 min read
Business
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.
March 11, 2024
·
15 min read
Funding
BrainChild Bio targets deadly pediatric brain cancer with $116M series A
BrainChild Bio’s lead asset BCB-276 is in pivotal development for diffuse intrinsic pontine glioma, a rare and fatal brain tumor that affects around 300 children in the U.S. every year.
September 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO) today announced financial results and recent corporate highlights for the third quarter that ended September 30, 2023.
November 14, 2023
·
16 min read
Press Releases
Mustang Bio Announces Closing of $8 Million Public Offering
February 11, 2025
·
5 min read
Press Releases
Mustang Bio Announces Pricing of $8 Million Public Offering
February 6, 2025
·
5 min read
Press Releases
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 12, 2025
·
3 min read
Genetown
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced its expansion into autoimmune diseases with MB-106, a personalized CD20-targeted, 3rd-generation autologous CAR T-cell therapy.
March 28, 2024
·
6 min read
1 of 53,896
Next
